Design, synthesis and biological evaluation of 2-indolinone derivatives as PAK1 inhibitors in MDA-MB-231 cells
作者:Dahong Yao、A. Ruhan、Jin Jiang、Jian Huang、Jinhui Wang、Weina Han
DOI:10.1016/j.bmcl.2020.127355
日期:2020.9
P21-activated kinase 1 (PAK1) plays a vital role in the proliferation, survival and migration of cancer cells, which has emerged as a promising drug target for cancer therapy. In this study, a series of 2-indolinone derivatives were designed and synthesized through a structure-based strategy. A potent PAK1 inhibitor (ZMF-005) was discovered, which presented an IC50 value of 0.22 μM against PAK1 with potent
P21活化激酶1(PAK1)在癌细胞的增殖,存活和迁移中起着至关重要的作用,而癌细胞已成为一种有希望的癌症治疗靶标。在这项研究中,通过基于结构的策略设计和合成了一系列2-吲哚酮衍生物。发现了一种有效的PAK1抑制剂(ZMF-005),它对具有有效抗增殖活性的PAK1的IC 50值为0.22μM。此外,我们通过分子对接和动态(MD)模拟预测了ZMF-005和PAK1的结合模式。另外,据报道ZMF-005在MDA-MB-231细胞中诱导明显的凋亡并抑制迁移。这些发现共同表明ZMF-005 是用于乳腺癌治疗的新型有效PAK1抑制剂。